University of California, San Diego | UCSD AntiViral Research Center

Research site

(Unclaimed)

Location

220 Dickinson Street, Suite A, San Diego, California, United States of America

Site insights

Top conditions

Top treatments

Ribavirin

Sofosbuvir

Emtricitabine

Tenofovir Disoproxil Fumarate

TDF

Interferon

Lenacapavir

KP-1461

PrEP

GS-0938

Parent organization

This site is a part of University of California, San Diego

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 25 total trials

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vac...

Active, not recruiting

HIV Infection

Hepatitis B

Biological: HEPLISAV-B

Biological: ENGERIX-B

DHFS for Medication Adherence Support During Hospital Admissions for Person Living With HIV

This study is a prospective single arm open label intervention study over 16 weeks using the DHFS and a telemedicine platform with persons living wit...

Active, not recruiting

HIV/AIDS

Device: Digital Health Feedback System(DHFS)

Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP)

This study uses an ingestion sensor and a wearable sensor (worn as a patch on the skin), which are new Proteus Digital Health (PDH) technologies appr...

Active, not recruiting

HIV Prevention

Device: Digital Health Feedback System

Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy

This study uses an ingestion sensor and a wearable sensor (worn as a patch on the skin), which are new Proteus Digital Health (PDH) technologies appr...

Active, not recruiting

HIV

Device: Digital Health Feedback System

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) (PURPOSE 4)

The goals of this clinical study are to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenof...

Enrolling

Pre-Exposure Prophylaxis of HIV Infection

Drug: Lenacapavir Tablet

Drug: Emtricitabine/tenofovir disoproxil fumarate (F/TDF)

Locations recently updated

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (PURPOSE 3)

The goal of this clinical study is to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenofov...

Enrolling

Pre-Exposure Prophylaxis of HIV Infection

Drug: Lenacapavir Tablet

Drug: Lenacapavir Injection